ISOPTO Drug Patent Profile
✉ Email this page to a colleague
When do Isopto patents expire, and what generic alternatives are available?
Isopto is a drug marketed by Alcon Labs Inc, Sandoz, and Alcon. and is included in four NDAs.
The generic ingredient in ISOPTO is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISOPTO?
- What are the global sales for ISOPTO?
- What is Average Wholesale Price for ISOPTO?
Summary for ISOPTO
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for ISOPTO |
| DailyMed Link: | ISOPTO at DailyMed |
US Patents and Regulatory Information for ISOPTO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | ISOPTO ATROPINE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 208151-001 | Dec 1, 2016 | AT2 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sandoz | ISOPTO CARPINE | pilocarpine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 200890-003 | Jun 22, 2010 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sandoz | ISOPTO CARPINE | pilocarpine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 200890-001 | Jun 22, 2010 | AT | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
